March 2020 Issue Table Of Contents

From The Editor

• Dear Readers — We Hear You

Feature Articles

• Jeff Albers’ Blueprint For Blueprint Medicines
• A Biopharma That Had To Pivot Twice To Forge Ahead

Capitol Perspectives

• Impeachment Halts Health Policy Advancement As Coronavirus Spreads

CEO Corner

• Effective Patient Engagement Starts With Strong Relationships

From Principles and Policy to Execution

• Policy Must Be All About People, Patients, & Populations. Is It?

Companies To Watch

• Adaptive Phage Therapeutics

Industry Research

• Pharmacovigilance Technology And The Adoption Of AI

Inside The Industry

• 5 Trends That Point To Another Decade Of Growth In Life Sciences
• The Inevitable Collision of AI Healthcare Technologies And Product Liability
• A New Life In Bio
• Nurturing A Nascent Colorado Biotech Hub
• Digital Transformation In The Life Sciences: The C-Suite Weighs In
• How Biopharma Came Together To Impact Poverty In Boston
• The Future Of Life Sciences Regulation: Adapt Or Die

Leadership Lessons

• Do You Make Your Own Luck?

Ask The Board

• What Book Had The Most Profound Impact On You Professionally?
• To Facilitate Introduction Of New Treatment/Technology More Rapidly, How Can Industry And Regulatory Agencies Work Together More Effectively?
• Will Technologies Like AI And Machine Learning Help Bring Down Drug Prices Globally?